Boogerd Leonora S F, Handgraaf Henricus J M, Lam Hwai-Ding, Huurman Volkert A L, Farina-Sarasqueta Arantza, Frangioni John V, van de Velde Cornelis J H, Braat Andries E, Vahrmeijer Alexander L
Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Surg Endosc. 2017 Feb;31(2):952-961. doi: 10.1007/s00464-016-5007-6. Epub 2016 Jun 29.
Tumor recurrence after radical resection of hepatic tumors is not uncommon, suggesting that malignant lesions are missed during surgery. Intraoperative navigation using fluorescence guidance is an innovative technique enabling real-time identification of (sub)capsular liver tumors. The objective of the current study was to compare fluorescence imaging (FI) and conventional imaging modalities for laparoscopic detection of both primary and metastatic tumors in the liver.
Patients undergoing laparoscopic resection of a malignant hepatic tumor were eligible for inclusion. Patients received standard of care, including preoperative CT and/or MRI. In addition, 10 mg indocyanine green was intravenously administered 1 day prior to surgery. After introduction of the laparoscope, inspection, FI, and laparoscopic ultrasonography (LUS) were performed. Histopathological examination of resected suspect tissue was considered the gold standard.
Twenty-two patients suspected of having hepatocellular carcinoma (n = 4), cholangiocarcinoma (n = 2) or liver metastases from colorectal carcinoma (n = 12), uveal melanoma (n = 2), and breast cancer (n = 2) were included. Two patients were excluded because their surgery was unexpectedly postponed several days. Twenty-six malignancies were resected in the remaining 20 patients. Sensitivity for various modalities was 80 % (CT), 84 % (MRI), 62 % (inspection), 86 % (LUS), and 92 % (FI), respectively. Three metastases (12 %) were identified solely by FI. All 26 malignancies could be detected by combining LUS and FI (100 % sensitivity).
This study demonstrates added value of FI during laparoscopic resections of several hepatic tumors. Although larger series will be needed to confirm long-term patient outcome, the technology already aids the surgeon by providing real-time fluorescence guidance.
肝肿瘤根治性切除术后肿瘤复发并不罕见,这表明手术过程中遗漏了恶性病变。使用荧光引导的术中导航是一种创新技术,能够实时识别肝包膜下(亚包膜下)肿瘤。本研究的目的是比较荧光成像(FI)和传统成像方式在腹腔镜检测肝脏原发性和转移性肿瘤中的应用。
符合条件的患者为接受腹腔镜肝恶性肿瘤切除术的患者。患者接受标准治疗,包括术前CT和/或MRI。此外,术前1天静脉注射10mg吲哚菁绿。插入腹腔镜后,进行检查、FI和腹腔镜超声检查(LUS)。切除的可疑组织的组织病理学检查被视为金标准。
纳入22例疑似肝细胞癌(n = 4)、胆管癌(n = 2)或结直肠癌肝转移(n = 12)、葡萄膜黑色素瘤(n = 2)和乳腺癌肝转移(n = 2)的患者。2例患者因手术意外推迟数天而被排除。其余20例患者共切除26个恶性肿瘤。各种检查方式的敏感性分别为80%(CT)、84%(MRI)、62%(检查)、86%(LUS)和92%(FI)。仅通过FI发现了3个转移灶(12%)。联合LUS和FI可检测到所有26个恶性肿瘤(敏感性100%)。
本研究证明了FI在几种肝肿瘤腹腔镜切除术中的附加价值。尽管需要更大规模的系列研究来证实患者的长期预后,但该技术已通过提供实时荧光引导帮助外科医生。